Anti-Interleukin-1 (Anti-IL-1) drugs are used to treat some chronic rheumatic diseases that can affect young people, including women of childbearing age. Two anti-IL-1 drugs are available in France: anakinra and canakinumab. Data on their use during pregnancy are still limited. Based on the published literature, we carried out a review of the use of these anti-IL-1 therapies during pregnancy: therapeutic indications, pharmacological profiles and assessment of embryonic, fetal and neonatal risks. Based on this analysis, and given the absence of any reported concern, it is possible to consider the use of these two treatments during pregnancy if the clinical situation so requires and under certain conditions. Based on the data available to date, anakinra should be preferred to canakinumab whenever possible.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gofs.2024.04.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Refractory Tophaceous Gout With Psoriatic Arthritis: A Case Report.
Cureus
November 2024
Internal Medicine, Unidade Local de Saúde de Santo António, Porto, PRT.
Although gout is a common intermittent crystalline arthropathy, tophaceous gout is a rare condition. Flares of this disease are usually treated with anti-inflammatory drugs followed by control of serum uric acid levels. We present a refractory, severe, tophaceous gout overlapping with psoriatic arthritis, presenting with a hyper-inflamed phenotype resistant to conventional anti-inflammatory and hypouricemic agents.
View Article and Find Full Text PDFUpdate on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases.
J Cardiovasc Med (Hagerstown)
January 2025
Cardiovascular Department, 'Azienda Sanitaria Universitaria Giuliano-Isontina', and University of Trieste, Trieste.
The knowledge of pericardial diseases has now improved, including prospective and retrospective cohort studies focusing on the pathogenesis, diagnosis, treatment, and outcomes. The complex interplay between genetic predisposition (especially for autoinflammatory conditions), inflammation, and autoimmunity is now known to trigger recurrences of pericarditis. Moreover, diagnostic capabilities have improved with the implementation of multimodality imaging, particularly cardiac magnetic resonance (CMR), to detect and monitor pericardial inflammation, to allow diagnosis in more complicated cases, and tailor the duration of therapy based on objective parameters.
View Article and Find Full Text PDFPhase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
November 2024
Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Trifluridine/tipiracil-bevacizumab is a standard of care in metastatic colorectal cancer (mCRC) after chemotherapy failure. We aim to assess the addition of XB2001 (anti-IL-1 alpha monoclonal antibody) plus trifluridine/tipiracil-bevacizumab in mCRC refractory to standard chemotherapy. This multicenter, randomized, double blind, non-comparative Phase I-II study (ClinicalTrials.
View Article and Find Full Text PDFAnakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene.
J Clin Med
October 2024
Department of Medicine (DMED), University of Udine, 33100 Udine, Italy.
: the role of the R202Q (c.605G>A, p.Arg202Gln) missense variant of the MEFV gene has been debated as either a benign polymorphism or a potentially pathogenic mutation.
View Article and Find Full Text PDFStill's Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management.
Drugs Aging
September 2024
Department of Rheumatology, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Article Synopsis
- - Still's Disease (SD) is a rare inflammatory condition marked by high fever, joint pain, and a transient rash, but older patients may experience atypical symptoms and higher complications like pleuritis and disseminated intravascular coagulation.
- - Older patients with SD tend to show increased levels of inflammatory markers and poorer outcomes, making diagnosis challenging due to overlapping symptoms with other diseases; hence, there's a cautious approach needed when diagnosing this age group.
- - Despite limited data, biologic treatments (like anti-IL-1 and anti-IL-6) may be effective in older patients, but the risk of severe complications necessitates a careful treatment strategy, highlighting a distinct need for focused attention on older adults with SD
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!